MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Abnormal streamline density of the tremor network in tremor dominant Parkinson’s disease and Essential tremor plus syndrome

    S. Prasad, J. Saini, R. Bharath, P. Pal (Bangalore, India)

    Objective: To evaluate streamline density (SD) of the basal ganglia-thalamocortical (BGTC) and cerebello-thalamocortical (CTC) network in tremor dominant Parkinson’s disease (TDPD) and essential tremor plus…
  • 2022 International Congress

    Capturing the complexity of patients with parkinsonism: Baseline characteristics of participants in the PRIME-UK cross-sectional study

    E. Tenison, D. Pendry-Brazier, M. Smith, F. Lithander, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: This cross-sectional study seeks to describe the symptomatology and health needs of a representative sample of people with parkinsonism, including those living with frailty,…
  • 2022 International Congress

    Frequency of depression and predictors of mood change among caregivers of Parkinson’s disease patients

    C. Iñiguez Alvarado, D. Santos García, T. Deus Fonticoba, C. Cores, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miró, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldente, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. ávila Rivera, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. García-Soto, C. Borrué, B. Solano Vila, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez Estrada, M. Seijo, J. Rúiz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González Ardura, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martinez-Martin, P. Mir (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the frequency of depression in a cohort of caregivers of patients with Parkinson ́s disease…
  • 2022 International Congress

    Developing infrastructure for a multi-arm multi-stage trial in Parkinson’s

    M-L. Zeissler, J. Allison, D. Athauda, S. Bartolomeu Pires, G. Baxendale, K. Bhatia, D. Breen, R. Chapman, H. Collins, R. Croucher, R. Ellis-Doyle, C. Gonzales-Robles, F. Hudson, R. Khengar, P. Korlipara, C. Lambert, G. Mills, A. Morgan, H. Morris, J. Rudiger, M. Silverdale, S. Wonnacott, A. Yarnall, T. Foltynie, C. Carroll, S. Mullin (Plymouth, United Kingdom)

    Objective: To scope and develop infrastructure for the first multi-arm multi-stage (MAMS) platform trial for Parkinson’s disease, the Edmond J Safra ACT-PD initiative (EJS ACT-PD).…
  • 2022 International Congress

    The key is “any movement”: results from a Cochrane systematic review and network meta-analysis on physical interventions for Parkinson´s disease

    M. Ernst, AK. Folkerts, M. Roheger, D. Chakraverty, F. Krohm, J. Caro-Valenzuela, R. Gollan, E. Lieker, A. Adams, C. Eggers, I. Monsef, A. Dresen, N. Skoetz, E. Kalbe (Cologne, Germany)

    Objective: To compare the efficacy and safety of physical interventions for people with Parkinson's disease (PD). Background: Physical interventions are effective in managing PD, but…
  • 2022 International Congress

    Parkinson disease with LRRK2 mutation associated with upper motor neuron dysfunction

    A. Rodriguez-Sanz, S. Serrano (MADRID, Spain)

    Objective: We report a patient with genetic Parkinson disease associated with upper motor neuron dysfunction. Background: Leucine-rich repeat kinase 2 (LRRK2) mutations have been extensively…
  • 2022 International Congress

    Correlation between clinical scales and gait in Parkinson’s disease

    A. Bitiati, C. de Oliveira, R. Treza, S. Hondo, E. Angeles, C. Bernardo, L. de Oliveira, M. Carvalho, M. Golin, D. Coelho (Santo André, Brazil)

    Objective: The objective of this study is to verify the correlations between cognitive and motor clinical scales and gait in individuals with PD and whether…
  • 2022 International Congress

    The changes in activities of daily livings after deep brain stimulation in Parkinson’s disease

    T. Yamamoto, M. Suzuki, S. Hirano, Y. Yamanaka, A. Sugiyama, N. Araki, Y. Higuchi, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify long-term changes in activities of daily living in patients with Parkinson's disease (PD) who underwent deep brain stimulation (DBS). Background:…
  • 2022 International Congress

    Personalized Medicine: Assessing the Needs of People with Young-Onset Parkinson’s Disease

    B. Mcdaniels, I. Subramanian, S. Kurian, S. Chitnis (Denton, USA)

    Objective: To identify the unmet needs of people with young-onset Parkinson’s disease (YOPD) with the goal of defining future research priorities. Background: YOPD is defined…
  • 2022 International Congress

    Socio-Clinical Factors Associated with Parkinson’s Disease Related Specific Self-Management Behaviors: The Role of Non-Motor Symptoms

    M. Kafri, M. Abu Taieh, M. Duvdevani, I. Schlesinger, M. Nassar, I. Erich, R. Hadad, G. Yogev-Seligmann (Haifa, Israel)

    Objective: To test associations between socio-clinical factors, self-management and patient activation among patients with Parkinson’s disease (PD), and to develop a predictive model for engagement…
  • « Previous Page
  • 1
  • …
  • 250
  • 251
  • 252
  • 253
  • 254
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley